(Q42226567)

English

Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals

scientific article published on 24 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

9

object named as

J van Lunzen

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

A Zoufaly

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

J G Kiepe

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

S Hertling

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

A Hüfner

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

O Degen

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

T Feldt

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

S Schmiedel

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

M Kurowski

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

24 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

449-457

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression

1 reference

https://api.crossref.org/works/10.1111%2FHIV.12134

21 January 2018

Identifiers

10.1111/HIV.12134

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42226567&oldid=1937083904"